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Abstract
Stromal Derived Factor 1 (SDF1 or CXCL12), is a chemokine known to be critical for the migration of cells in several tissue
systems including the homing of the hematopoietic stem cell (HSC) to its niche in the bone marrow. A comparative analysis
of miRNA expression profiles of two stromal cell lines, distinguishable by function and by CXCL12 expression (CXCL12
+ and
CXCL12
2), revealed that the CXCL12
2 cells expressed .40 fold more miR-886-3p than the CXCL12
+ cells. Screening studies
showed that when miR-886-3p was transfected into the CXCL12
+ stromal cells, the expression of CXCL12 was down-
regulated by as much as 85% when compared to appropriate controls, and results in the loss of CXCL12-directed
chemotaxis. Similar reductions in CXCL12 were obtained with the transfection of miR-886-3p into primary stromal cell
cultures. Additional studies showed that miR-886-3p specifically targeted the 39 untranslated region (UTR) of CXCL12 mRNA.
These data suggest a role for miRNA in modulating the expression of CXCL12, a gene product with a critical role in
hematopoietic regulation.
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Introduction
SDF1 or CXCL12 is a chemokine which binds specifically to the
G-protein coupled receptor, CXCR4 [1]. Although originally
isolated from murine marrow stromal cells, CXCL12 is now known
to be expressed in several cell types, as is its cognate receptor,
CXCR4. In vitro and in vivo studies have now established the
critical role CXCL12/CXCR4 interactions play in the directed
migration of cells within tissues. In the hematopoietic system, stem
and progenitor cells express CXCR4 and migrate to their niches
along a gradient of CXCL12 expressed by the cellular components
of the niche[2],[3]. Neuronal migration during development utilizes
this ligand-receptor system [4] as do tumor cells metastasizing from
their primary site to their metastatic niches [5]. Knock-out mice
lacking either the ligand or the receptor are embryonic lethal, with
defects in multiple organs [4], [6].
In the hematopoietic system, CXCL12 is now known to be
amongst several factors that contribute to a functional stem cell
niche [3]. Other stem-cell niche defining genes identified in the
past several years include Jagged1[7], Angiopoietin1[8], BMP4[9],
Osteopontin[10], and N-Cadherin[11]. How the cellular elements
in the niche express these factors in a coordinated fashion is not
known. For instance, CXCL12 is down-regulated by cytokines
such as IL1 [12] and FGF2 [13], but this appears to be promoter-
independent. We hypothesized that trans-regulatory factors such
as transcription factors and/or microRNAs (miRNAs) are likely
involved in coordinating the expression of CXCL12. We further
hypothesized that stromal cell lines that differed in CXCL12
expression could be used in a comparative analysis to identify
differentially expressed miRNAs that may be responsible for
controlling CXCL12 expression.
We have previously reported on two stromal cell lines, derived
from one human primary long term culture, that have distinguish-
able functional characteristics and gene expression profiles [14].
One termed HS27a expresses high levels of CXCL12 and niche-
associated genes and functions to support primitive hematopoietic
precursors in specialized areas of culture called cobble-stone areas.
In contrast, a second line termed HS5 expresses low levels niche-
associated ligands, but secretes high levels of IL1, IL6 and GCSF,
factors which drive hematopoietic precursors to differentiate and
proliferate. Consequently HS5 also does not support formation of
cobble stone areas. Using miRNA microarrays, we identified miR-
886-3p to be expressed 40 fold greater in HS5 compared to HS27a.
Interestingly, the primary transcript of miR-886-3p was recently
reported to be the RNA component of a ribonucleoprotein called
vault [15]. In this report we show that miR-886-3p directly targets
the 39UTR of CXCL12 mRNA, significantly down-regulating the
expression and function of CXCL12. The ability of miR-866-3p to
decrease CXCL12 expression was also observed in primary stromal
cells derived from long term marrow cultures and in non-stromal
cancer cell lines known to express CXCL12.
Results
Human Stromal Cell line HS27a expresses HSC niche–
associated ligands
Mesenchyme-derived stromal fibroblasts (also referred to as
marrow stromal cells, mesenchymal stem cells, or MSC) are now
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defined by both in vivo and in vitro models [16]. Although the
term MSC has come to imply that these cells are homogenous, it is
now recognized that the MSC population contains subsets with
distinct functions, although isolating these subsets by surface
labeling has been difficult. However, recently the expression of
CD146 (MCAM or Melanoma Cell Associated Molecule) has
been reported to define a subset of stromal precursors that
contribute to the stem cell niche [17]. We speculated that since the
HS27a stromal cell line seemed to share similar functional and
transcriptional profiles with those reported for the CD146
hi
stromal precursors, it might also express high levels of CD146.
We performed flow-cytometric analysis of CD146 on HS27a and
HS5 cells and determined that CD146 was expressed strongly by
HS27a, whereas HS5 did not (Figure 1A). We then evaluated
CD146 expression in 9 primary cultures, established from normal
bone marrow. The cultures which were analyzed within the first
two to three passages demonstrated variable proportions of
CD146
hi cells (6 to 40%), an example of which is shown in
Figure 1B. The CD146
hi and CD146
lo cells from primary
cultures were then evaluated for expression of two genes deemed
critical to the stem cell niche, CXCL12 and Angiopoietin 1. As
shown in Figures 1C and 1D, the CD146
hi population has
significantly higher expression of both CXCL12 and Angiopoietin
1 when compared to CD146
lo cells. Thus CD146
hi stromal cells
from primary cultures retain the expression profile associated with
the HSC niche. HS27a also expresses these niche associated genes;
this together with its functional phenotype makes it a relevant
model for at least one cellular component of the HSC niche.
The stromal cell lines HS5 and HS27a have distinct
miRNA expression profiles
To test our hypothesis that miRNAs may influence the
expression levels of niche-associated genes, we first determined
the miRNA expression profiles of the functionally distinct HS27a
and HS5 cell lines. 1610
6 cells of each cell line, in log-phase growth
were harvested and total RNA including the small non-coding
fraction were isolated and submitted for miRNA analysis. Of the
810 human miRNAs arrayed, 156 had statistically different
expression levels in the two cell lines. Table 1 provides a partial
list of 10 miRNAs over-expressed in HS27a when compared to
HS5, and Table 2 provides a list of miRNAs over expressed in
HS5 when compared to HS27a. The complete data-set is available
in the geo omnibusdatabase as well in Table S1. The 48-fold over-
Figure 1. Expression of CD146, CXCL12 and Angiopoietin 1 in stromal cells and primary long term cultures (LTCs). A: FACS analysis of
stromal cell lines HS5 and HS27a for CD146 (MCAM) along with isotype controls. B: FACS analysis of a primary LTC at first passage for CD146 along
with isotype control. The primary LTCs were sorted to CD146
hi and CD146
lo populations by FACS-aided flow-sorting. Approximate gates for hi and lo
populations are also indicated. C: CXCL12 levels of 9 LTCs sorted to CD146
hi and CD146
lo and quantitated by RT-PCR (relative to beta-actin, multiplied
by a factor of 1000). Paired samples from the same culture are connected by a line. D: Angiopoietin-1 levels of the same 9 LTCs, also quantitated by
RT-PCR (relative to beta-actin, multiplied by a factor of 10000). Experiment in panel A was confirmed in three independent experiments, Experiments
in panels B, C and D were confirmed in 9 independent samples. Statistical analysis of the datasets in Panels C and D by Wilcoxon’s matched pair test
revealed a p-value of ,0.01 in both cases.
doi:10.1371/journal.pone.0014304.g001
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a profound expression difference was likely to have functional
consequences.
MiR-886-3p has been described in both humans [18] and
macaques [19] by deep sequencing of small RNA libraries, but it
has not been detected by size fractionating (such as by Northern
blotting). Interestingly, the primary transcript of miR-886-3p is
now thought to be a component of vaults (a ribonucleoprotein
particle) and has been annotated vtRNA-2[15]. It has been
suggested that miR-886-3p might not be a microRNA [20],
however as shown in Figure 2A, both the 121 nucleotide primary
transcript and the 21-nucleotide miR-886-3p are detectable by
northern blotting with higher levels in HS5 cells compared to
HS27a. This confirms that the 21 nucleotide long miR-886-3p is
indeed processed from the primary transcript and hence is a
genuine miRNA.
Our results are in agreement with a report by Persson et. al that
show other vault RNAs (vtRNA-1) can be processed to smaller
functional counterparts through a Drosha-independent but dicer-
dependent mechanism [21]. Similarly, small nucleolar RNA
(snoRNA) were found to be processed by Dicer to smaller 20-22
nucleotide RNAs with miRNA-like functions [22]. Results from
microarray analysis and northern blot were confirmed by
quantitative RT-PCR. As shown in Figure 2B, HS5 was shown
to have a 50-fold higher level of miR-886-3p compared to HS27a.
Quantitation of miRNAs was done by a modification of the stem-
loop reverse transcription method described by Chen et al.;
primers used are listed in Table S2. Results were normalized to
the expression of a non-coding small RNA, U48. Although miR-
886-3p homologues have not been described in non-primates,
vault RNAs have been described in all vertebrates including
mouse. It is conceivable that functional miRNAs may arise out of
processing of this precursor non-coding RNAs. This work is
currently on-goin.
Primary marrow-derived CD146
hi stromal cells that
express niche associated gene products express lower
levels of miR-886-3p
Results suggested that CD146 expression defined a primary
stromal cell population that has functional and transcriptome
profiles similar to that of HS27a. To extend the comparison we
tested whether CD146
hi population of primary stromal cells also
have a lower expression of miR-886-3p when compared to the
CD146
lo population. Nine primary stromal cell cultures were
harvested before passage three and sorted into CD146
hi and
CD146
lo populations. Total RNA was prepared from both
populations and reverse transcribed with primers specific for miR-
886-3p and U48. Quantitative RT-PCR was then performed and
analyzed; results are shown in Figure 2C. As anticipated, primary
LTCs have significant variation in basal expression of miR-886-
3p. However, the CD146
hi population had a significantly lower
expression of miR-886-3p when compared’ to the CD146
lo
population. This indicates that primary marrow stromal cells are
similar to HS27a in that their expression of CD146 and CXCL12
are associated with relatively low expression levels of miR-886-3p.
CXCL12 is a target of miR-886-3p
Although HS5 and HS27a were derived from the same culture,
they differentially express several genes that define the stem cell
niche, as well as miR-886-3p. We hypothesized that miR-886-3p
expression may be responsible for some of these differences. We
began by analyzing the targets of 886-3p as defined by commonly
used prediction algorithms, miRBASE (http://microrna.sanger.
ac.uk/sequences/) [23] and miRANDA (http://www.microrna.
org/microrna/home.do) [24]. However no predicted matches
with any of the ‘‘niche-defining’’ genes were identified. Neverthe-
less we proceeded with studies to determine the effect of miR-886-
3p on select gene expression. This was justified by our
understanding that; 1) the prediction algorithms that match
miRNAs to potential binding sites in target mRNA are often
imperfect, relying on binding site homologies across species; miR-
886-3p has been described only in Homo sapiens and Macacus mulata
and hence homology comparisons may not be relevant across
several species; and 2) the effect of miR-886-3p on the above genes
of interest may be indirect and hence not apparent by target
prediction algorithms.
The select mRNAs quantified included Jagged-1(JAG1),
Angiopoietin1 (Ang1), CXCL12, Bone Morphogenetic Protein4
(BMP4), N-Cadherin (CDH2), VCAM-1 and Frizzled 4(FZD4).
Amongst these, CXCL12 was found to be markedly down
regulated by miR-886-3p transfection when compared to controls.
The other genes had insignificant changes in expression level (data
not shown). Figure 3A shows that the maximum down regulation
of CXCL12 was attained on Day 4 when levels falls as much as
Table 1. miRNAs over-expressed in HS27a.
Sanger ID Accession Number Ratio (HS27a/HS5) p value
hsa-miR-181a MIMAT0000256 4.96 0.01
hsa-miR-21 MIMAT0000076 2.92 0.01
hsa-miR-181b MIMAT0000257 2.38 ,0.01
hsa-miR-224 MIMAT0000281 2.30 0.01
hsa-miR-21* MIMAT0004494 2.23 0.01
hsa-miR-7 MIMAT0000252 2.17 0.01
hsa-miR-299-5p MIMAT0002890 1.79 0.01
hsa-miR-31 MIMAT0000089 1.77 0.01
hsa-miR-25 MIMAT0004498 1.75 0.01
hsa-miR-155 MIMAT0000646 1.67 ,0.01
Partial list of miRNAs significantly over-expressed in HS27a when compared to
HS5. Three independent samples were analyzed for microRNA expression
profile.
doi:10.1371/journal.pone.0014304.t001
Table 2. miRNAs over-expressed in HS5.
Sanger ID Accession Number Ratio(HS5/HS27a) p value
hsa-miR-886-3p MIMAT0004906 48.49 ,0.01
hsa-miR-9 MIMAT0000441 2.97 0.01
hsa-miR-193a-3p MIMAT0000459 2.93 ,0.01
hsa-miR-365 MIMAT0000710 2.52 0.02
hsa-miR-210 MIMAT0000267 2.31 0.04
hsa-miR-26b MIMAT0004500 2.28 ,0.01
hsa-miR-146a MIMAT0000449 2.10 0.04
hsa-miR-222 MIMAT0000279 2.10 0.02
hsa-miR-149 MIMAT0000450 2.08 ,0.01
hsa-miR-148a MIMAT0000243 2.01 0.01
Partial list of miRNAs significantly over-expressed in HS5 when compared to
HS27a. Three independent samples were analyzed for the microRNA expression
profile.
doi:10.1371/journal.pone.0014304.t002
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As shown in Figure 3B, at day 5 post transfection the levels of
secreted CXCL12 were significantly reduced in supernatants from
cells transfected with miR-886-3p compared to controls. We also
achieved the stable over-expression of miR-886-3p achieved by
cloning a 363 bp fragment that includes the 121bp primary
transcript using the MDH1-PGK GFP retroviral vector [25] (as
obtained from Chang-Zhen Chen’s laboratory at Stanford
University through Addgene, plasmid #11375). This strategy also
resulted in reliable down-regulation of CXCL12 in HS27a cells
(Figure 3C). The retroviral vector is represented in Figure 4A.
The down-regulation of CXCL12 was also seen in primary
stromal fibroblasts obtained from long term cultures (LTCs).
Despite variability in the basal expression level of CXCL12, 6 of 8
primary stromal cultures also showed significantly decreased
expression of CXCL12 at 48 hours after transfection
(Figure 3D). We also confirmed the down regulation of CXCL12
by miR-886-3p in non-stromal cell lines (U87MG, A375, T47D
and MCF7, data not shown).
Further evidence for the association of miR-886-3p with
CXCL12 expression came from complementary experiments in
which the expression level of miR-886-3p was knocked down in
HS5 cells by transient transfection of anti-sense locked nucleic acid
(LNA) probes. Results are shown in Figure 3E. Using the same
MDH1-PGK-GFP retroviral vectors described above, we then
proceeded to perform stable knock-down of miR-886-3p in HS5
cells by the expression of ‘‘microRNA sponges’’. miRNA sponges
are oligonucleotides consisting of 8-fold repeats of antisense-
sequence to the particular miRNA, which acts like a sponge to
‘‘mops-up’’ the free miRNA [26]. HS5 cells with stable-knock-
down of miR-886-3p had increased CXCL12 expression compa-
rable to that obtained with transient knock-down using LNA-
probes. Details of the miR-886-3p sponge are shown in Figure 4B
and 4C. Taken together, we conclude that miR-886-3p is a
regulator of CXCL12 expression in marrow stromal cells.
CXCL12 39UTR is a direct target of miR-886-3p
To determine if CXCL12 mRNA is a direct target for miR-886-
3p binding, we cloned the full length 39 UTR of CXCL12 from
genomic DNA and inserted it downstream of the renilla luciferase
gene in the psi-Check2 plasmid (Figure 5A) to create the psi-SDF-
UTR plasmid. The psi-check2 plasmid has both the firefly
luciferase and renilla luciferase expressed from constitutive
promoters. The 39 UTR cloned immediately downstream of the
Renilla luciferase gene is expected to modulate the expression of
Renilla luciferase alone; firefly luciferase serves as an internal
control to which the expression of renilla luciferase can be
normalized [27]. Stromal cells were co-transfected with miR-886-
Figure 2. miR-886-3p expression in stromal cells. A: Northern Blotting for has-miR-886-3p. The 121 bp primary transcript of miR-886-3p
and the 21 bp mature miR-886-3p are detected by by Northern blotting using a probe antisense to mature miR-886-3p (21 nucleotides). Both the
primary transcript and mature miRNA are expressed at a higher level in HS5 cells. The primary transcript was visible at lower exposure times (typically
,4 hours) compared to the mature 21 bp transcript (typically overnight exposure). B: miR-886-3p expression in HS5 compared and HS27a,
normalized to the expression of U48, a small non-coding RNA. Results are expressed as a ratio of HS5 levels over HS27a levels for three samples
shown are mean of three samples, 6SE (Standard Error). C: Expression of miR-886-3p in CD146 high and CD146 low populations of 9 primary long-
term cultures (LTCs) in early passages, also determined by q RT PCR. Paired samples are connected by a line. Statistical analysis was performed by
Wilcoxon matched pair test, a non-parametric test using GraphPad Prism software, which shows a p-value ,0.01.
doi:10.1371/journal.pone.0014304.g002
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PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e14304Figure 3. Regulation of CXCL12 by miR-886-3p. A: Time course of CXCL12 mRNA expression for 5 days after miR-886-3p compared to control
miRNA mimic transfection, as determined by q RT PCR. Results normalized to expression of a house keeping gene beta-actin. CXCL12 expression in
cells transfected with miR-886-3p was significantly different from control transfected cells on all 5 days (p,0.05). Results shown as mean of three
samples 6 SE. B: Time course of secreted levels of CXCL12 in conditioned media of HS27a transfected by miR-886-3p or control miRNA as determined
by quantitative ELISA. A standard curve was constructed using dilutions of recombinant CXCL12 to calculate concentration in individual samples.
Results expressed as pg/ml, and are the mean of three samples, 6 SE. CXCL12 levels were significantly different (p,0.05) in miR-886-3p transfected
and control transfected media only on day 5. C: CXCL12 gene expression in HS27a cells after stable transfection of miR-886-3p primary transcript
(363 bp in length) by a gamma-retro viral vector. Control transfections had no insert at the corresponding site. Results expressed as a ratio to beta-
actin expression, p value ,0.05. D: CXCL12 gene expression in 8 primary fibroblast cultures (derived from LTCs) after 48 hours of transfection with
miR-886-3p or control miRNA. Paired samples are connected by a line. Statistical analysis performed by Wilcoxon matched pair test, p value was
,0.05. E: Up regulation of CXCL12 in HS5 cells after down-regulation of miR-886-3p at 48 and 72 hours after transfection. MiRNA antagonists (locked
nucleic acid or LNA probes against miR-886-3p or a negative control) were transfected by reverse transfection; (p,0.05 at 72 hours). F: CXCL12 gene
expression in HS5 cells after stable transfection of ‘‘miR-886-3p sponge’’ primary transcript (363 bp in length) by a gamma-retro viral vector. Control
transfections had no insert at the corresponding site.(p value ,0.05).
doi:10.1371/journal.pone.0014304.g003
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using a dual luminometer. When the 886-3p mimic was co-
transfected with psi-SDF-UTR we detected a 70% reduction in
renilla luciferase expression compared to control (Figure 5C).
This suggests that the predominant effect of miR-886-3p in
decreasing CXCL12 expression is mediated through its 39UTR.
To identify the miR-886-3p binding site within the UTR we
initially used the target prediction program (miRANDA and
miRBase). However these programs did not reveal any putative
binding sites presumably due to the need for cross-species
validation in their algorithms (miR-886-3p has only been
described in humans and macacus mulata). We then used the
RNA22 algorithm (http://cbcsrv.watson.ibm.com/rna22_targets.
html) [27], which did show alignment of the putative seed region
within the UTR. Three nucleotides of the putative 7 nucleotide
seed region were then mutated as shown in Figure 5B by site
directed mutagenesis to disrupt the binding of miR-886-3p. This
mutation reduced the suppressive effect of miR-886-3p on the
luciferase activity when compared to the unmutated UTR, as
shown in Figure 5D. Further evidence for a direct effect of miR-
886-3p on the CXCL12 UTR came from analysis of the 39 UTR
in HS5 cells. As HS5 has high endogenous expression of miR-886-
3p, plasmids were transfected alone without transfection of
additional miRNA precursors. As shown in Figure 4E, mutating
the putative binding site on the UTR increased luciferase activity
significantly, again suggesting that the down regulation of
CXCL12 is effected by miR-886-3p through direct binding to
the putative binding site.
miR-886-3p transfection of HS27a decreases chemotaxis
of Jurkat cells
To determine the functional significance of miR-886-3p
mediated down regulation of CXCL12, we measured the effect
of transfected mir-886-3p on the chemo-attractant activity of
HS27a conditioned media. The Jurkat T-lymphoid cell line has a
well documented chemotactic response to CXCL12 [28], which is
secreted by HS27a (Figure 2B). In these experiments conditioned
media from HS27a cells transfected with miR-886-3p or with
controls miRNAs, were collected 5 days after transfection and
placed in the lower chamber of a trans-well. Jurkat cells were
plated in the upper chamber separated by a porous membrane
(5 m pore size). The migration of Jurkat cells to the lower chamber
was quantitated after 3 hours, per published methodology [28]. In
addition to CXCL12, HS27a conditioned media is likely to have
other molecules with chemo-attractant properties, hence several
controls were included; CXCL12 at 50 ng/ml as a positive control
and RPMI 1640 with 10% fetal calf serum as a negative control.
Results shown in Figure 6A indicate that transfection of miR-
866-3p into HS27a cells significantly reduced the ability of HS27a
conditioned media to support Jurkat chemotaxis. As positive
controls, there was a partial inhibition of the chemotactic effect by
both a neutralizing antibody to CXCL12 or pre-treatment with a
Figure 4. Stable Expression of miR-886-3p or its knock-down using viral vectors. A: MDH1-PGK-EGFP retroviral vector for the stable
expression of miR-886-3p and miRNA sponge. The constitutively active PGK promoter drives the expression of EGFP while the Pol III promoter H1
drives the expression of the 363 bp genomic DNA fragment that includes the primary transcript, or the miRNA sponge. B: The miRNA sponge. A
240 bp transcript with 8 repeats of 21 mers partially homologous to miR-8863p was synthesized and cloned into the EcoRI-XhoI site of MDH1 vector.
C: Sequence of miRNA sponge. A ‘‘bubble’’ region is included as per initial reports that partial non-homology improves the binding and down-
regulation of the miRNA.
doi:10.1371/journal.pone.0014304.g004
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Importantly the reduced chemo-attractant potential of condi-
tioned media from miR-886-3p transfected HS27a cells was not
further reduced by addition of either the neutralizing antibody or
AMD3100. This suggests that the conditioned media from the
miR-866-p3 transfected HS27a cells was already depleted of
CXCL12 (Figure 6C). Taken together, CXCL12 mRNA down
regulation by miR-886-3p inhibits function attributable to
CXCL12.
Discussion
Mesenchyme-derived stromal fibroblasts (also referred to as
marrow stromal cells, mesenchymal stem cells, or MSC) are now
known to play a critical role in the regulation of hematopoiesis as
defined by both in vivo and in vitro models [16]. Although the
term MSC has come to imply that these cells are homogenous, it is
now recognized that the MSC population contains subsets with
distinct functions, although isolating these subsets by surface
labeling has been difficult [30]. Our group has previously used the
STRO-1 antibody to isolate the bone marrow mononuclear cells
(BMMNC) capable of forming colony forming unit fibroblasts
(CFU-F) [31]. Recently, CD146 or MCAM was used by Sacchetti
et al to define the subset of stromal fibroblasts that contribute to a
stem cell niche. In this study, we have used functionally distinct
stromal cell lines that have been extensively characterized for their
ability to influence hematopoiesis. And in agreement with
Sacchetti’ et. Al’s observations, the line that supports progenitor
cells in their undifferentiated state, HS27a, expresses high levels of
CD146. This is in contrast to a second line, HS5, isolated from the
same primary culture but significantly different in function.
Little is known as to how distinct functional compartments are
specified within this compartment of stromal cells. Trans-
activating factors such as transcription factors and microRNAs,
a newly described class of small non-coding RNAs are likely
involved in this regulation. MicroRNAs (miRNAs) are a class of
small (usually <22 nucleotides long) non-coding RNAs whose
importance in regulating diverse genes has been only recently
identified [32], [33]. MiRNAs are transcribed as primary
transcripts of variable length or arise from intronic regions of
mRNAs, and are then serially processed enzymatically by the
Drosha and Dicer complexes to generate the mature miRNA [34].
They are now known to negatively regulate gene expression by
binding to the 39 untranslated region (39UTR) of mature mRNAs
in a sequence-specific manner and repressing gene expression by
either initiating degradation of the mRNA or by preventing it’s
translation to a peptide[35].
In this report, we provide evidence that CXCL12, a critical
component of the stem-cell niche is regulated, at least in part, by
miR-886-3p. This miRNA has been previously described by deep
sequencing of small RNA libraries and is most abundant in
connective-tissues, but not demonstrated by hybridization to a
size-fractionated RNA sample (such as Northern Blotting), which
is considered a pre-requisite to denoting a small RNA as a
Figure 5. Analysis of effect of miR-886-3p on 39UTR of CXCL12. A: psi2-CXCL12-UTR vector with both firefly luciferase (fLuc+) as internal
control and Renilla luciferase (hRluc) upstream of the UTR construct. B: Putative binding site of miR-886-3p on the CXCL12 UTR along with the 3
nucleotide mutation in the seed region (termed Mut-UTR). C: Luciferase assay for psi-SDF-UTR in HS27a cells when co-transfected with miRNA control
mimic or miR-886-3p. Results normalized to control transfections (with irrelevant miRNA mimic) which is assigned a value of 1, p,0.05. D: Luciferase
activity of psi-mut-UTR in HS27a cells when co-transfected with miRNA control mimic or miR-886-3p. E: Luciferase activity of psi-UTR or psi-mut-UTR
in HS5 cells, no miRNA co-transfection, p,0.05. All luciferase measurements were made in triplicates and readings were performed at 48 hours after
transfection are represented as 6 SE.
doi:10.1371/journal.pone.0014304.g005
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primary transcript of miR-886-3p may be the RNA component of
a ribonucleoprotein (RNP) called vault [15] and that the transcript
may not be a miRNA [20]. Hence we first sought to demonstrate
that the 121-nuceotide-long primary transcript and the 21
nucleotide mature miRNA could be detected in the stromal cell
lines by northern blotting. In addition to direct demonstration of
the miRNA, our results extend the recent observations that small
regulatory RNAs may be derived from non-coding RNA
precursors that may have alternative functions (in this case, as
part of a ribonucleoprotein).
The profound down-regulation of CXCL12 by miR-886-3p
along with its up-regulation when the miRNA is knocked down
suggests that this miRNA is a major regulator of CXCL12.
Interestingly, several prediction algorithms (miRBASE, miRAN-
DA and target scan) failed to predict the binding of miR-886-3p’s
seed region to the 39 UTR of CXCL12. However a binding site
was predicted by the RNA22 algorithm which does not rely on
cross-species conservation of binding sites for prediction. These
results highlight the limitations of current bioinformatic prediction
algorithms for identifying miRNA-mRNA binding of potential
significance [37], [38]. Using mutation studies of the putative
binding site predicted by RNA22 we were able to confirm that the
CXCL12 39 UTR is a direct target of miR-886-3p.
The regulatory properties of miRs on diverse genes (over 30%
of human genes are now thought to be directly regulated by miRs
[39]) has added an additional layer of complexity to our
understanding of the regulation of gene expression. The
chemokine CXCL12 and its receptor CXCR4 are now known
to be critical for the homing of HSC and their progeny to
Figure 6. Chemotaxis Assay with Jurkat Cells. A: Chemotaxis of Jurkat cells in response to Control miRNA mimic transfection or mir-886-3p
transfection of HS27a cells. Media was collected after 5 days of transfection and used for chemotaxis assay. Controls included CXCL12 (50 ng/ml) and
RPMI1640 with10% FCS. B: Chemotaxis of Jurkat cells to control mimic transfected HS27a media. Controls include the same media treated with
neutralizing anti-SDF1 antibody, or mouse IgG1 antibodies at 100 ug/ml, or pre-treatment of Jurkat cells with 1000 ng/ml of AMD3100. The
neutralizing antibody or AMD3100 reduced the chemotactic response of Jurkat cells. C: Chemotaxis of Jurkat cells to mir-886-3p transfected HS27a
media. The same controls are used as in Panel B. Treatment with inhibitors (neutralizing antibody or AMD3100 failed to change the chemotaxis of
Jurkat cells. All samples were done in triplicates. Statistical comparisons of relevance that reach significance by student t-test (p,0.05) are indicated
by ‘‘*’’.
doi:10.1371/journal.pone.0014304.g006
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known to be secreted by diverse cell types, in the hematopoietic
ME, stromal cells (termed CXC12 abundant reticular cells or
CAR) are thought to be its major source. MiR-126 [41], [42] and
miR-23a [43] have been previously reported to regulate the
expression of CXCL12. Interestingly, these miRNAs were not
expressed differentially between the two stromal cell lines that we
interrogated. Cytokines such as IL1beta[12] and FGF2[13],[44]
are now known to be associated with the down regulation of
CXCL12, but interestingly, neither of these cytokines have a
significant effect on the CXCL12 promoter[44],[45]. In fact,
FGF2 has been shown to affect the stability of CXCL12 mRNA
[44]. Our results suggest that miR-886-3p may play a critical role
in CXCL12 expression. As CXCL12 is known to direct homing in
diverse tissues and play a role in tumor metastases, it is likely that
miR-886-3p expression is likely to be of significance in the
regulation of both normal and disease tissue.
Although the coordinated expression of several genes by several
different cell types is required to define a functional stem cell
niche, the regulation of this coordinated expression is not well
understood. Defining the role of miR-886-3p in stromal expression
of CXCL12 raises the possibility that regulatory RNAs may play a
wide role in regulating the hematopoietic niche. Identifying the
trans-acting factors, including transcription factors and miRs,
involved in regulating the hematopoietic ME would facilitate the
identification of therapeutic targets for diseases such as myelodys-
plastic syndrome (MDS) in which the marrow ME itself is known
to be dysregulated[46],[47]. The recently described techniques of
cross-linked immunoprecipitation (CLIP) [48] which relies on pull-
down of RNA-argonaute complexes by immunoprecipitation
should aid in a system-wide dissection of miRNA-mRNA
interactions of functional significance, which was previously
limited to bioinformatics based analysis.
Materials and Methods
Cell culture, FACS analysis, and sorting
All samples from human volunteers used in the study were
obtained in accordance with protocols approved by the Institu-
tional Review Board (IRB) at the Fred Hutchinson Cancer
Research Center (FHCRC) and the University of Colorado.
Human Stromal cell lines HS5 and HS27A and Jurkat cells were
grown in RPMI-1640 supplemented with 10% Fetal Calf Serum
(FCS) and Penicillin (100 U/ml and streptomycin (100 mg/mL).
A375, T47D and MCF7 cells were grown in DMEM supple-
mented with 10% FCS and Penicillin-Streptomycin. Jurkat,
U87MG, A375, T47D and MCF7 cells were obtained from
ATCC (Manassas, VA). Primary stromal fibroblasts were cultured
from bone marrow mononuclear cells (BMMNC) as previously
described [49]. Cells were stained with FITC-conjugated anti-
CD146 antibody (Ebiosciences, San Diego, CA) as well as
appropriate isotype control for analysis as well as cell sorting in
to CD146
hi and CD146
lo populations on a FACS Aria cell sorter
(BD Biosciences, San Jose, CA).
Transfection of miRNA mimics and inhibitors and
retroviral transfection for stable cell lines
Both stromal cell lines and primary stromal cells were
transfected by ‘‘reverse transfection’’(cells were added after the
lipid-RNA complex) with Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA) in a 12 well format. Other cells were transfected
with regular lipofectamine 2000 transfection per manufacturer’s
instructions on adherent cell cultures, reagents volumes and cell
numbers were as described for stromal cells. For miRNA over-
expression, miRNA mimics from Dharmacon were used at a
concentration of 10 nmol along with negative control mimics. For
stable expression of miRNAs, a 363 bp genomic region that
included the primary transcript of miR-886-3p was cloned into the
BamHI-EcoRI site of the previously described MDH1-PGK-GFP
vector (Addgene plasmid 11376). Control vectors had no insert.
Positive cells were selected for GFP expression by FACS-sorting
and single cell colonies were isolated by ring-cloning. MiR-886-3p
was confirmed by quantitative RT-PCR. For transient miRNA
knock-down, locked nucleic acid (LNA) probes along with negative
controls (Exiqon, Denmark) were used at a concentration of
50 nmol. Stable knock-down was attained by the use of
‘‘microRNA sponges’’ expressed using the MDH1-PGK-GFP
vector, the sponge was designed based on previous reports[26] and
custom synthesized by Genscript (Piscataway, New Jersey) with
BamHI and EcoRI sites at the end. Cells were sorted and cloned
as for the over-expressing cells. Details of the retroviral vectors and
the miRNA sponges are shown in Figure 4. Sequence of miRNA
sponge and primers used are listed in Table S2.
RNA preparation, miRNA microarray, Northern Blotting
and quantitative RT-PCR
For purposes of microarray analysis and quantitative RT-PCR,
total RNA was prepared using the miRNEasy kit (Qiagen,
Valencia, CA) per manufacturer’s instructions; on-column DNAse
digestion was performed to eliminate contamination with genomic
DNA. For northern blotting, total RNA was prepared using Trizol
reagent (Invitrogen) per manufacturer’s instructions. MiRNA
microarray was performed by Thermo Scientific Dharmacon
(Lafayette, CO) on three samples each of HS27a and HS5 and
analyzed using textbook ANOVA. For northern blotting, total
RNA was separated on a 12% polyacrylamide/8M urea gel on a
Protean II apparatus (Biorad, Hercules, CA) and transferred to
positive charged nylon membrane using Trans-Blot semi-dry
electrophoretic cell (Biorad). The nylon membrane was UV cross-
linked and baked at 80uC and probed with P-32 labeled antisense
LNA probes (Exiqon). The membrane was then washed and
exposed to X-ray film for varying lengths of time.
MiRNAs were quantitated by SYBR-GREEN based quantita-
tive Real Time-Polymerase Chain Reaction (q RT-PCR) on
cDNA generated by reverse transcription using a specific stem-
loop primer as previously reported. Expression of miR-886-3p was
expression was normalized between different samples based on
expression of U48 (SNORD48; NR_002745), a small nuclear
RNA. Intron-spanning primers were used to quantify CXCL12
mRNA expression and normalized to beta-actin, also by SYBR-
GREEN based q RT-PCR assay. Conditions for PCR were 95
degrees for 10 seconds and 60 degrees for 1 minute, for 40 cycles.
All products were sequence verified by either direct sequencing of
the DNA product or cloning after TA cloning.
ELISA for CXCL12 levels
Enzyme Linked Immune Sorbent Assay (ELISA) for secreted
CXCL12levelswereperformed onconditionedmediafromstromal
cells using the Duoset ELISA Development kit (RnD Systems,
Minneapolis, MN) per manufacturer’s instructions and read on the
Synergy micro plate reader (Biotek, Winooski, VT) at 450 nm. A
standard curve was constructed using the provided standard for
quantification of optical density (OD) values for individual samples.
DNA Constructs and Luciferase Reporter Assay
The 1.5 Kbp length 39 UTR of CXCL12 (NCBI Reference
NM_199168) was cloned from human genomic DNA with high-
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and cloned into psiCheck2 vector (Promega, Madison, WI). To
generate mutants of binding sites, site directed mutagenesis was
performed using Pfu Turbo Polymerase (Stratagene, Lajolla, CA)
and primers designed by Stratagene’s Quikchange Primer Design
Program (http://www.stratagene.com/sdmdesigner/default.aspx).
All clones were sequence-verified by DNA sequencing. For the
dual luciferase assay, 0.4 ug of plasmid was co-transfected with
10 nmol 886-3p mimic or control mimic in 12 well plates as
described for transfection with the miRNA alone. At 48 hours, the
cells were lysed and assayed for both renilla and fire-fly luciferase
using the Dual Luciferase Reporter Assay kit on a GLOMAX
micro plate luminometer (both from Promega).
Chemotaxis Assay
The assays were performed as previously described by Cherla et
al [28]. Briefly, Jurkat cells in log-growth phase were washed twice
in PBS and 10610
6 cells were suspended in RPMI 1940 with
2.5% FCS. The assays were performed in 24 well plates with 5 mm
porosity inserts (Corning Inc, Corning NY). 600 ml of conditioned
media (or media with antibody) was loaded to the lower chamber,
100 ml of the cell suspension (total of 1610
6 cells) was added to the
upper chamber. To some wells, mouse anti-human CXCL12
neutralizing antibody (clone 79014) or control mouse IgG1
antibody (both RnD Systems) were added at 100 ug/ml, the
ND50 of this neutralizing antibody has been determined to be 30
to 60 ug/ml. Some wells had the cells treated with the CXCR4
receptor inhibitor AMD3100
22 (Sigma Aldrich, St Louis, MO) at
1000 ng/ml concentration for 30 to 60 minutes to block the
CXCR4 pathway. Recombinant human CXCL12 (RnD Systems)
was added to some wells at 50 ng/ml as positive control. Plates
were incubated for 3 hours at 37 deg C in a humid Tissue Culture
chamber at 5% CO2, the inserts were then removed and the
viable cells in the bottom chamber quantified with a hemocytom-
eter. All wells were repeated in triplicates.
Statistical Analysis
Textbook ANOVA was used in the differential expression
analysis of HS5 vs. HS27A. Student t-test or Wilcoxon matched-
pair test was used to determine statistical significance using
GraphPad Prism software (La Jolla, CA), a p value of less than
0.05 was deemed statistically significant.
Supporting Information
Table S1 Microarray analysis of HS27a and Hs5 cell lines.
Found at: doi:10.1371/journal.pone.0014304.s001 (0.05 MB
XLSX)
Table S2 Primers used in various experiments described in the
manuscript.
Found at: doi:10.1371/journal.pone.0014304.s002 (0.05 MB
XLS)
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